It is imperative to classify opportunistic skin pathogens and skin commensals for the
Malassezia genus of lipophilic yeasts. Recently, in the eastern and western United States, nine types of bat skins have isolated as new
Malassezia species in the subfamily
Myotinae. Factually,
[...] Read more.
It is imperative to classify opportunistic skin pathogens and skin commensals for the
Malassezia genus of lipophilic yeasts. Recently, in the eastern and western United States, nine types of bat skins have isolated as new
Malassezia species in the subfamily
Myotinae. Factually, wild-type
Malassezia insulates are typically susceptible to azoles, except for fluconazole, although developed azole resistance in these strains has been related to either alterations or quadruplications of the
ERG11 gene. Those remarks have provoked interest in substitute antifungal therapy, such as chlorhexidine, and different plant essential oils. The purposes of this investigation were to assess atopic dermatitis (AD) along with the
Malassezia species and the adequacy of its inhibitory effect with different plant essential oils against pathogenic
Malassezia isolates. Plants produce essential oils because of physiological stresses, microorganism assaults, and biological variables. Essential oils are complex volatile compounds, integrated normally in various plant parts during the cycle of secondary metabolism. Yeasts of the class Malassezia have been associated with various ailments influencing the human skin, for example, psoriasis, atopic dermatitis, dandruff, seborrheic dermatitis, folliculitis,
Malassezia (
Pityrosporum) and pityriasis Versicolor, and—less commonly—with other dermatologic issues, for example, transient acantholytic dermatosis, onychomycosis, and reticulated and confluent papillomatosis.
Malassezia is a significant causal factor for seborrheic dermatitis. Studies exploring cell and humoral immune responses explicit to
Malassezia species in patients with
Malassezia-related infections and healthy controls have commonly not been able to characterize critical contrasts in their resistant reactions. Presently, few medications are accessible to treat this fungal infection. The current examination is expected to enhance the clinical utilization of essential oils; there is an urgent need to conduct further in vivo investigations with large cohorts of patients to confirm the clinical capability of essential oils against
Malassezia species.
Full article